| 1,4-dithiothreitol | multiple interactions | ISO | RGD:1315043 | 6480464 | Dithiothreitol inhibits the reaction [NCX 4040 inhibits the reaction [TXN1 protein binds to MAP3K5 protein]] | CTD | PMID:18922898 |
| 1-chloro-2,4-dinitrobenzene | increases phosphorylation | ISO | RGD:1315043 | 6480464 | Dinitrochlorobenzene results in increased phosphorylation of MAP3K5 protein | CTD | PMID:21628959 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1315043 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MAP3K5 mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | increases expression | ISO | RGD:1315043 | 6480464 | Estradiol results in increased expression of MAP3K5 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1315043 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MAP3K5 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1315043 | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAP3K5 mRNA | CTD | PMID:22574217 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1315043 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MAP3K5 mRNA | CTD | PMID:19619570 |
| 3-methyladenine | multiple interactions | ISO | RGD:1315043 | 6480464 | 3-methyladenine inhibits the reaction [MAP3K5 protein results in decreased phosphorylation of MTOR protein]; more ... | CTD | PMID:20929985 |
| 3-methyladenine | affects response to substance | ISO | RGD:1315043 | 6480464 | 3-methyladenine affects the susceptibility to MAP3K5 protein | CTD | PMID:20929985 |
| 4-vinylcyclohexene dioxide | increases expression | ISO | RGD:1306565 | 6480464 | 4-vinyl-1-cyclohexene dioxide results in increased expression of MAP3K5 mRNA | CTD | PMID:23274565 |
| aflatoxin B1 | affects expression | ISO | RGD:1315043 | 6480464 | Aflatoxin B1 affects the expression of MAP3K5 protein | CTD | PMID:20106945 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1315043 | 6480464 | Tretinoin results in increased expression of MAP3K5 mRNA | CTD | PMID:21934132 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of MAP3K5 mRNA | CTD | PMID:22498432 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1315043 | 6480464 | Benzo(a)pyrene results in decreased expression of MAP3K5 mRNA | CTD | PMID:20064835 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MAP3K5 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of MAP3K5 mRNA | CTD | PMID:21715664 |
| cadmium dichloride | multiple interactions | ISO | | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein] | CTD | PMID:18703135 |
| cadmium dichloride | increases phosphorylation | ISO | RGD:1306565 | 6480464 | Cadmium Chloride results in increased phosphorylation of MAP3K5 protein | CTD | PMID:18021293 PMID:18703135 |
| cadmium dichloride | increases activity | ISO | RGD:1315043 | 6480464 | Cadmium Chloride results in increased activity of MAP3K5 protein | CTD | PMID:16337887 |
| cadmium dichloride | increases phosphorylation | ISO | RGD:1306565 | 6480464 | Cadmium Chloride results in increased phosphorylation of MAP3K5 protein | CTD | PMID:18703135 PMID:18021293 |
| cadmium dichloride | multiple interactions | ISO | RGD:1306565 | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein] | CTD | PMID:18703135 |
| cadmium dichloride | increases phosphorylation | ISO | RGD:1315043 | 6480464 | Cadmium Chloride results in increased phosphorylation of MAP3K5 protein | CTD | PMID:18703135 |
| cadmium dichloride | multiple interactions | ISO | RGD:1315043 | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein] | CTD | PMID:18703135 |
| cadmium dichloride | increases phosphorylation | ISO | | 6480464 | Cadmium Chloride results in increased phosphorylation of MAP3K5 protein | CTD | PMID:18021293 PMID:18703135 |
| calcitriol | multiple interactions | ISO | RGD:1315043 | 6480464 | [Calcitriol promotes the reaction [TXNIP protein binds to TRN protein]] which results in increased activity of MAP3K5 protein | CTD | PMID:10843682 |
| calcitriol | increases activity | ISO | RGD:1315043 | 6480464 | Calcitriol results in increased activity of MAP3K5 protein | CTD | PMID:10843682 |
| camptothecin | decreases expression | ISO | RGD:1315043 | 6480464 | Camptothecin results in decreased expression of MAP3K5 mRNA | CTD | PMID:17374387 |
| chloroethene | decreases expression | EXP | | 6480464 | Vinyl Chloride results in decreased expression of MAP3K5 mRNA | CTD | PMID:18579281 |
| chromium(6+) | multiple interactions | ISO | RGD:1315043 | 6480464 | chromium hexavalent ion inhibits the reaction [TXN protein binds to MAP3K5 protein] | CTD | PMID:19703554 |
| ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of MAP3K5 mRNA | CTD | PMID:18353800 |
| cisplatin | decreases expression | ISO | RGD:1315043 | 6480464 | Cisplatin results in decreased expression of MAP3K5 mRNA | CTD | PMID:19561079 |
| copper atom | multiple interactions | ISO | RGD:1315043 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of MAP3K5 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1315043 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of MAP3K5 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of MAP3K5 mRNA | CTD | PMID:18579281 |
| crocidolite asbestos | affects expression | ISO | RGD:1315043 | 6480464 | Asbestos, Crocidolite affects the expression of MAP3K5 mRNA | CTD | PMID:17331233 |
| D-glucose | increases expression | ISO | RGD:1315043 | 6480464 | Glucose results in increased expression of MAP3K5 protein | CTD | PMID:16731828 |
| D-glucose | multiple interactions | ISO | RGD:1315043 | 6480464 | Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein] | CTD | PMID:14505347 |
| D-glucose | multiple interactions | ISO | RGD:1315043 | 6480464 | Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein | CTD | PMID:16731828 |
| daunorubicin | decreases expression | ISO | RGD:1315043 | 6480464 | Daunorubicin results in decreased expression of MAP3K5 mRNA | CTD | PMID:17374387 |
| desferrioxamine B | multiple interactions | ISO | RGD:1315043 | 6480464 | Deferoxamine inhibits the reaction [Plant Extracts results in increased phosphorylation of MAP3K5 protein] | CTD | PMID:20206247 |
| diazoxide | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of MAP3K5 mRNA | CTD | PMID:21335049 |
| dimethyl sulfoxide | multiple interactions | ISO | RGD:1306565 | 6480464 | Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in increased activity of MAP3K5 protein] | CTD | PMID:12370186 |
| dimethyl sulfoxide | decreases activity | ISO | | 6480464 | Dimethyl Sulfoxide results in decreased activity of MAP3K5 protein | CTD | PMID:12370186 |
| dimethyl sulfoxide | multiple interactions | ISO | | 6480464 | Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in increased activity of MAP3K5 protein] | CTD | PMID:12370186 |
| dimethyl sulfoxide | decreases activity | ISO | RGD:1306565 | 6480464 | Dimethyl Sulfoxide results in decreased activity of MAP3K5 protein | CTD | PMID:12370186 |
| dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of MAP3K5 mRNA | CTD | PMID:17441966 |
| edaravone | decreases activity | EXP | | 6480464 | phenylmethylpyrazolone results in decreased activity of MAP3K5 protein | CTD | PMID:15824197 |
| elemental selenium | decreases expression | ISO | RGD:1315043 | 6480464 | Selenium results in decreased expression of MAP3K5 mRNA | CTD | PMID:19244175 |
| ethanol | multiple interactions | EXP | | 6480464 | ALDH2 protein inhibits the reaction [Ethanol results in increased phosphorylation of MAP3K5 protein] | CTD | PMID:19332462 |
| ethanol | increases phosphorylation | EXP | | 6480464 | Ethanol results in increased phosphorylation of MAP3K5 protein | CTD | PMID:19332462 |
| etoposide | decreases expression | ISO | RGD:1315043 | 6480464 | Etoposide results in decreased expression of MAP3K5 mRNA | CTD | PMID:17374387 |
| eugenol | increases phosphorylation | ISO | RGD:1315043 | 6480464 | Eugenol results in increased phosphorylation of MAP3K5 protein | CTD | PMID:21628959 |
| formaldehyde | decreases expression | ISO | RGD:1315043 | 6480464 | Formaldehyde results in decreased expression of MAP3K5 mRNA | CTD | PMID:23416264 |
| glucose | increases expression | ISO | RGD:1315043 | 6480464 | Glucose results in increased expression of MAP3K5 protein | CTD | PMID:16731828 |
| glucose | multiple interactions | ISO | RGD:1315043 | 6480464 | Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein] | CTD | PMID:14505347 |
| glucose | multiple interactions | ISO | RGD:1315043 | 6480464 | Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein | CTD | PMID:16731828 |
| hydrogen peroxide | increases activity | ISO | RGD:1306565 | 6480464 | Hydrogen Peroxide results in increased activity of MAP3K5 protein | CTD | PMID:15629441 |
| hydrogen peroxide | increases expression | ISO | | 6480464 | Hydrogen Peroxide results in increased expression of MAP3K5 protein | CTD | PMID:16157298 |
| hydrogen peroxide | increases activity | ISO | | 6480464 | Hydrogen Peroxide results in increased activity of MAP3K5 protein | CTD | PMID:15629441 |
| hydrogen peroxide | increases expression | ISO | RGD:1306565 | 6480464 | Hydrogen Peroxide results in increased expression of MAP3K5 protein | CTD | PMID:16157298 |
| indole-3-methanol | affects expression | ISO | RGD:1306565 | 6480464 | indole-3-carbinol affects the expression of RGD1306565 mRNA; more ... | CTD | PMID:21396975 |
| isoprenaline | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of MAP3K5 mRNA | CTD | PMID:21335049 |
| kainic acid | decreases expression | EXP | | 6480464 | Kainic Acid results in decreased expression of MAP3K5 mRNA | CTD | PMID:17997037 |
| L-ascorbic acid | multiple interactions | ISO | RGD:1315043 | 6480464 | Ascorbic Acid inhibits the reaction [Plant Extracts results in increased phosphorylation of MAP3K5 protein] | CTD | PMID:20206247 |
| mercury dichloride | increases activity | ISO | RGD:1315043 | 6480464 | Mercuric Chloride results in increased activity of MAP3K5 protein | CTD | PMID:16337887 |
| N-acetyl-L-cysteine | multiple interactions | ISO | | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein] | CTD | PMID:18703135 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1306565 | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein] | CTD | PMID:18703135 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1315043 | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein] | CTD | PMID:18703135 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]] | CTD | PMID:16449798 |
| paclitaxel | multiple interactions | ISO | RGD:1315043 | 6480464 | MAP3K5 protein affects the reaction [Paclitaxel results in increased activity of CASP3 protein]; more ... | CTD | PMID:10075725 |
| paracetamol | multiple interactions | EXP | | 6480464 | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of AK5 mRNA]; more ... | CTD | PMID:18700144 |
| paracetamol | decreases expression | ISO | RGD:1315043 | 6480464 | Acetaminophen results in decreased expression of MAP3K5 mRNA | CTD | PMID:21420995 |
| paracetamol | increases response to substance | EXP | | 6480464 | MAP3K5 protein results in increased susceptibility to Acetaminophen | CTD | PMID:18700144 |
| paracetamol | increases activity | EXP | | 6480464 | Acetaminophen results in increased activity of MAP3K5 protein | CTD | PMID:18700144 |
| paraquat | multiple interactions | ISO | RGD:1315043 | 6480464 | [Paraquat co-treated with MAP3K5 protein] results in increased degradation of SQSTM1 protein; more ... | CTD | PMID:20929985 |
| paraquat | multiple interactions | ISO | RGD:1315043 | 6480464 | Paraquat results in increased phosphorylation of and results in increased activity of MAP3K5 protein; more ... | CTD | PMID:19735704 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of MAP3K5 mRNA | CTD | PMID:19270015 |
| phenylacetaldehyde | increases phosphorylation | ISO | RGD:1315043 | 6480464 | phenylacetaldehyde results in increased phosphorylation of MAP3K5 protein | CTD | PMID:21628959 |
| phenylephrine | multiple interactions | ISO | RGD:1306565 | 6480464 | CAMK2D protein promotes the reaction [Phenylephrine results in increased activity of MAP3K5 protein]; more ... | CTD | PMID:15629441 |
| phenylephrine | increases activity | ISO | | 6480464 | Phenylephrine results in increased activity of MAP3K5 protein | CTD | PMID:15629441 |
| phenylephrine | multiple interactions | ISO | | 6480464 | CAMK2D protein promotes the reaction [Phenylephrine results in increased activity of MAP3K5 protein]; more ... | CTD | PMID:15629441 |
| phenylephrine | increases activity | ISO | RGD:1306565 | 6480464 | Phenylephrine results in increased activity of MAP3K5 protein | CTD | PMID:15629441 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of MAP3K5 mRNA | CTD | PMID:18445702 |
| raloxifene | multiple interactions | ISO | RGD:1315043 | 6480464 | [Raloxifene co-treated with ESR2 protein] results in decreased expression of MAP3K5 mRNA | CTD | PMID:19059307 |
| resveratrol | increases activity | ISO | RGD:1315043 | 6480464 | resveratrol results in increased activity of MAP3K5 protein | CTD | PMID:15217905 |
| rotenone | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]] | CTD | PMID:16449798 |
| selenium atom | decreases expression | ISO | RGD:1315043 | 6480464 | Selenium results in decreased expression of MAP3K5 mRNA | CTD | PMID:19244175 |
| sevoflurane | increases phosphorylation | ISO | RGD:1315043 | 6480464 | sevoflurane results in increased phosphorylation of MAP3K5 protein | CTD | PMID:18349187 |
| sodium dichromate | decreases expression | EXP | | 6480464 | sodium bichromate results in decreased expression of MAP3K5 mRNA | CTD | PMID:22155349 |
| sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of MAP3K5 mRNA | CTD | PMID:22155349 |
| streptozocin | multiple interactions | EXP | | 6480464 | Streptozocin promotes the reaction [MAP3K5 protein results in increased expression of SERPINE1 protein] | CTD | PMID:16731828 |
| succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAP3K5 mRNA | CTD | PMID:21641980 |
| tamoxifen | multiple interactions | ISO | RGD:1315043 | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in decreased expression of MAP3K5 mRNA | CTD | PMID:19059307 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1315043 | 6480464 | tert-Butylhydroperoxide results in increased expression of MAP3K5 mRNA | CTD | PMID:15336504 |
| thioacetamide | multiple interactions | ISO | | 6480464 | Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in increased activity of MAP3K5 protein] | CTD | PMID:12370186 |
| thioacetamide | increases activity | ISO | RGD:1306565 | 6480464 | Thioacetamide results in increased activity of MAP3K5 protein | CTD | PMID:12370186 |
| thioacetamide | multiple interactions | ISO | RGD:1306565 | 6480464 | Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in increased activity of MAP3K5 protein] | CTD | PMID:12370186 |
| thioacetamide | increases activity | ISO | | 6480464 | Thioacetamide results in increased activity of MAP3K5 protein | CTD | PMID:12370186 |
| trans-resveratrol | increases activity | ISO | RGD:1315043 | 6480464 | resveratrol results in increased activity of MAP3K5 protein | CTD | PMID:15217905 |
| troglitazone | multiple interactions | ISO | RGD:1315043 | 6480464 | mito-carboxy proxyl inhibits the reaction [troglitazone results in increased activity of MAP3K5 protein] | CTD | PMID:17975114 |
| troglitazone | increases activity | ISO | RGD:1315043 | 6480464 | troglitazone results in increased activity of MAP3K5 protein | CTD | PMID:17975114 |
| tunicamycin | multiple interactions | ISO | RGD:1315043 | 6480464 | Tunicamycin results in increased phosphorylation of and results in increased activity of MAP3K5 protein | CTD | PMID:19735704 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of MAP3K5 mRNA | CTD | PMID:17292431 |